Stay updated with breaking news from Hyperfine Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hyperfine, Inc. (NASDAQ:HYPR – Free Report) – B. Riley increased their Q3 2024 earnings estimates for shares of Hyperfine in a report released on Wednesday, May 15th. B. Riley analyst Y. Zhi now anticipates that the company will post earnings of ($0.13) per share for the quarter, up from their previous estimate of ($0.14). The […]
Hyperfine (NASDAQ:HYPR – Get Free Report) is scheduled to be announcing its earnings results after the market closes on Monday, May 13th. Analysts expect the company to announce earnings of ($0.14) per share for the quarter. Hyperfine has set its Q1 2024 guidance at EPS and its FY 2024 guidance at EPS.Parties that wish to […]
Hyperfine (NASDAQ:HYPR – Get Free Report) and Fc Global Realty (OTCMKTS:FCRE – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, dividends, valuation and earnings. Analyst Recommendations This is a summary of […]
Hyperfine (NASDAQ:HYPR – Get Free Report) and CONMED (NYSE:CNMD – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability and analyst recommendations. Analyst Ratings This is a summary of recent ratings and […]
Hyperfine (NASDAQ:HYPR – Get Free Report) and Nexalin Technology (NASDAQ:NXL – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation. Analyst Recommendations This is a breakdown of recent […]